Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis C treatment news

Show

From To
CHMP Grants Positive Opinion for Shorter Treatment Duration with AbbVie's VIEKIRAX® for Patients with Genotype 4 Chronic Hepatitis C with Compensated Cirrhosis (Child-Pugh A)

AbbVie announced today that the European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has granted a positive opinion for the use of 12 weeks of VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) with ribavirin (RBV) in genotype 4 (GT4) chronic hepatitis C virus (HCV) infected adult patients with compensated cirrhosis (Child-Pugh A). VIEKIRAX with RBV is currently approved in the European Union for GT4 patients with compensated cirrhosis for 24 weeks.

Published
12 hours ago
From
Manual Items
Sofosbuvir/velpatasvir shows high cure rate in HIV/HCV co-infection study

The once-daily co-formulation of sofosbuvir and velpatasvir was highly effective against all hepatitis C virus (HCV) genotypes in people with HIV/HCV co-infection and was safe and well

Published
21 July 2016
By
Liz Highleyman
WHO Updates Patent Status Info For New Hepatitis C Medicines

The World Health Organization has issued updated information on the patent status of hepatitis C medicines, including assessments of hurdles for affordable generic versions of latest drugs.

Published
21 July 2016
From
Intellectual Property Watch
'World has ignored hepatitis at its peril,' warns UN health agency ahead of World Day

With some 400 million people around the world infected with hepatitis B or C, the United Nations health agency today encouraged countries to boost testing and access to services and medicines for people in need.

Published
21 July 2016
From
UN News Centre
Fast Advance in Hepatitis C Care Prompts EMA to Revise Clinical Trial Guideline

EMA has proposed changes to its guideline on clinical trials of direct acting antiviral hepatitis C drugs. The revisions are intended to ensure the guideline reflects the dramatic changes that have happened in the hepatitis C sector since Gilead introduced its blockbuster Sovaldi (sofosbuvir).

Published
17 July 2016
From
Regulatory Affairs Professionals Society
'It's Destroyed People's Lives': The Shocking Rise in Hepatitis C-Related Deaths

Hepatitis C is preventable and curable—but it now kills more Americans than any other disease. According to experts, stigma against intravenous drug users and sex workers may be to blame.

Published
22 June 2016
From
VICE
What Do Gilead And Martin Shkreli Have In Common?

The U.S. Attorney for Massachusetts issued Gilead a subpoena pursuant to donations to charities that help patients pay for drugs. Medicare prohibits drug makers from helping patients afford their copays. The investigation could result in a ban on donations to copay charities, a decline in Gilead's customer retention and/or a fall in revenue.

Published
22 June 2016
From
Seeking Alpha
Hepatitis C: Treating People Who Inject Drugs

How can HCV specialists best work with addiction centers to bring potential patients into more complete and comprehensive HCV care?

Published
21 June 2016
From
HCV Next
Fighting the War on HCV Within the Veterans Health Administration System

Hepatitis C virus challenges the Veterans Health Administration in much the same way it challenges others, but with the added burden of post-traumatic stress disorder and a host of other military-specific hurdles, it presents unique challenges for treatment.

Published
21 June 2016
From
HCV Next
Punjab: Government launches special fund for free treatment of Hepatitis C

With this initiative, Punjab has become the first state in the country to provide free treatment to confirmed cases of Hepatitis C, a spokesperson claimed.

Published
20 June 2016
From
Indian Express
← First12345...79Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close